文献速递肝胆胰外科围术期管理与 ERAS

术前经皮经肝胆管引流对Ⅲ、Ⅳ型肝门部胆管癌手术的影响

[Effects of preoperative percutaneous transhepatic biliary drainage on surgical treatment of type Ⅲ and Ⅳ hilar cholangiocarcinoma].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2019-01-01

该回顾性研究分析72例Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌患者,比较术前经皮经肝胆管引流(PTBD)减黄组31例与未减黄组41例的手术效果。结果显示减黄可缩短手术时间、减少术中出血和并发症,但R0切除率及1、3、5年生存率无显著差异。

要点

  • 术前PTBD减黄可缩短手术时间、减少术中出血量和术后并发症发生率。
  • 减黄对R0切除率及1、3、5年生存率无明显影响。
  • 减黄组无围手术期死亡,未减黄组有2例围手术期死亡。

核心结论

  • Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌术前PTBD减黄可缩短手术时间、减少术中出血量和术后并发症发生率。
  • 术前PTBD减黄对R0切除率和生存率无明显影响。

研究设计与样本

  • 回顾性分析2010年1月至2017年12月蚌埠医学院第一附属医院普通外科收治的72例行手术治疗的Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌患者临床资料。
  • 按术前是否行PTBD减黄分为减黄组31例(男20例、女11例,年龄(59.9±9.7)岁)与未减黄组41例(男26例、女15例,年龄(60.8±7.8)岁)。
  • 计量资料用t检验,计数资料用χ²检验,生存曲线用Kaplan-Meier法绘制。

主要发现

  • 减黄后ALT(93.2±21.4)U/L、AST(87.6±18.1)U/L、总胆红素(68.8±12.6)μmol/L分别较减黄前(207.4±65.1)U/L、(188.9±56.6)U/L、(227.5±87.7)μmol/L下降,差异有统计学意义(t=10.958、10.845、10.386,P=0.000)。
  • 减黄组较未减黄组手术时间短、术中出血量少、并发症发生率低(t=-2.840,P=0.006;t=-3.698,P=0.000;χ²=4.108,P=0.043)。
  • 减黄组无围手术期死亡,未减黄组有2例围手术期死亡。
  • 两组R0切除率差异无统计学意义(χ²=0.778,P=0.378)。
  • 减黄组与未减黄组1、3、5年生存率分别为72.7%、34.2%、13.7%与72.8%、31.5%、11.8%,差异无统计学意义(P值均>0.05)。

临床怎么用

  • 对Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌黄疸患者,术前可考虑超声引导下PTBD减黄以改善围手术期结果。
  • 应向患者说明术前减黄不改变R0切除率与远期生存,决策需结合个体情况。

局限性

  • 本研究为单中心回顾性分析,样本量72例,结果需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effects of preoperative percutaneous transhepatic biliary drainage on surgical treatment of type Ⅲ and Ⅳ hilar cholangiocarcinoma. Methods: Clinical data of 72 patients with hilar cholangiocarcinoma of the Bismuth-Corlette type Ⅲ and Ⅳ treated at Department of General Surgery,First Affiliated Hospital of Bengbu Medical College from January 2010 to December 2017 were analyzed retrospectively.Patients were divided into two groups based on whether PTBD was performed:a drained group and an undrained group.In the drained group,there were 31 patients,20 males and 11 females,aged (59.9±9.7)years (range: 39-73 years).Among them,14 patients underwent hepatectomy with half or more than half of the liver removed (extended hepatectomy)and 17 patients underwent non-anatomical hepatectomy in the hilar region (limited hepatectomy).In the undrained group,there were 41 patients, 26 males and 15 females, aged (60.8±7.8)years(range: 45-75 years).Among them, 17 patients underwent hepatectomy with half or more than half of the liver removed (extended hepatectomy)and 24 patients underwent non-anatomical hepatectomy in the hilar region (limited hepatectomy).Percutaneous transhepatic biliary drainage(PTBD)was used in the drained group.Under the guidance of ultrasound,one or more hepatobiliary ducts could be sufficiently drained,which had good effect and was not restricted by the obstruction location of hilar cholangiocarcinoma.The analysis of the measurement data was performed using t test,and the analysis of the count data was performed using χ(2) test,and the survival curve was plotted using Kaplan-meier method. Results: In total, 72 jaundiced patients with hilar cholangiocarcinoma underwent surgical treatment: 31 had PTBD prior to operation while 41 did not had PTBD.There were significant differences in ALT((93.2±21.4)U/L vs.(207.4±65.1)U/L),AST((87.6±18.1)U/L vs.(188.9±56.6)U/L)and total bilirubin((68.8±12.6)μmol/L vs.(227.5±87.7)μmol/L)between the patients after treatment and those before treatment(t=10.958, P=0.000; t=10.845, P=0.000; t=10.386, P=0.000).Compared with those in the undrained group, the operation time was shorter, the amount of intraoperative bleeding and the incidence of complications were lower in the drained group(t=-2.840, P=0.006; t=-3.698, P=0.000; χ(2)=4.108, P=0.043).There were no perioperative death cases in drained group and 2 perioperative death cases in undrained group.There was no significant difference in R0 resection rate between the two groups(χ(2)=0.778,P=0.378).The 1-,3-,5-year survival rate of patients in the drained group and the undrained group was 72.7%,34.2%, 13.7% and 72.8%, 31.5%, 11.8%, respectively.The difference was not statistically significant(all P>0.05). Conclusions: The preoperative percutaneous transhepatic biliary drainage in patients with hilar cholangiocarcinoma of Bismuth-Corlette type Ⅲ and Ⅳ could effectively shorten operative time, reduce amount of intraoperative bleeding and incidence of postoperative complications,but have no significant effect on the R0 resection rate and survival rate. 目的: 探讨术前减黄对Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌手术治疗的影响。 方法: 回顾性分析2010年1月至2017年12月蚌埠医学院第一附属医院普通外科收治的72例行手术治疗的Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌患者的临床资料。根据术前是否减黄治疗分为减黄组和未减黄组。减黄组31例患者,男性20例,女性11例,年龄(59.9±9.7)岁(范围:39~73岁),其中半肝及以上肝切除患者(扩大肝切除)14例,肝门区肝组织非解剖性切除术(局限肝切除)17例。未减黄组41例患者,男性26例,女性15例,年龄(60.8±7.8)岁(范围:45~75岁),其中半肝及以上肝切除(扩大肝切除术)17例,肝门区肝组织非解剖性切除(局限肝切除术)24例。术前减黄组均采用经皮经肝胆管引流术,在超声引导下可以对一个或多个肝胆管进行胆汁充分引流,具有较好的减黄效果,且不受制于肝门部胆管癌梗阻位置的高低。计量资料的分析使用t检验,计数资料的分析使用χ(2)检验;使用Kaplan-Meier方法绘制生存曲线。 结果: 72例患者中,术前行减黄治疗31例,术前未行减黄治疗41例。减黄治疗后患者的ALT[(93.2±21.4)U/L]、AST[(87.6±18.1)U/L]、总胆红素[(68.8±12.6)μmol/L]分别与减黄治疗前[(207.4±65.1)U/L、(188.9±56.6)U/L、(227.5±87.7)μmol/L]比较,差异有统计学意义(t=10.958,P=0.000;t=10.845,P=0.000;t=10.386,P=0.000)。减黄组患者相比未减黄组患者手术时间短、术中出血量少和并发症发生率低,差异有统计学意义(t=-2.840,P=0.006;t=-3.698,P=0.000;χ(2)=4.108,P=0.043)。减黄组无围手术期死亡病例,未减黄组有2例围手术期死亡患者。减黄组患者R0切除率与未减黄组患者比较,差异无统计学意义(χ(2)=0.778,P=0.378)。减黄组患者1、3、5年总体生存率分别为72.7%、34.2%、13.7%,未减黄组患者分别为72.8%、31.5%、11.8%,差异无统计学意义(P值均>0.05)。 结论: Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌患者术前减黄治疗可以缩短手术时间、减少术中出血量和术后并发症的发生率,但对患者的R0切除率和生存率无明显影响。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang DD, Xu JZ, Fu Q, et al. [Effects of preoperative percutaneous transhepatic biliary drainage on surgical treatment of type Ⅲ and Ⅳ hilar cholangiocarcinoma]. Zhonghua Wai Ke Za Zhi. 2019. PMID: 30929375. doi:10.3760/cma.j.issn.0529-5815.2019.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。